Detalhe da pesquisa
1.
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.
Blood
; 132(25): 2639-2642, 2018 12 20.
Artigo
Inglês
| MEDLINE | ID: mdl-30266774
2.
Increased Efficacy of Stem Cell Chemomobilization with Intermediate-Dose Cytarabine Plus Granulocyte Colony-Stimulating Factor (G-CSF) Compared with G-CSF Alone in Patients with Multiple Myeloma: Results of a Randomized Trial.
Biol Blood Marrow Transplant
; 25(2): 248-255, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30266677
3.
Safety Analysis of Brentuximab Vedotin from the Phase III AETHERA Trial in Hodgkin Lymphoma in the Post-Transplant Consolidation Setting.
Biol Blood Marrow Transplant
; 24(11): 2354-2359, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29859255
4.
Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation.
Contemp Oncol (Pozn)
; 22(2): 113-117, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30150889
5.
Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.
Am J Hematol
; 92(4): 359-366, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-28103640
6.
Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma.
Br J Haematol
; 175(5): 860-867, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27649689
7.
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 385(9980): 1853-62, 2015 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-25796459
8.
Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.
Ann Hematol
; 95(2): 263-9, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26611854
9.
Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial.
Blood
; 121(10): 1720-8, 2013 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-23315161
10.
Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
Am J Hematol
; 90(10): 904-9, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26149802
11.
Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.
Blood
; 127(3): 360-2, 2016 Jan 21.
Artigo
Inglês
| MEDLINE | ID: mdl-26567156
12.
A faster reconstitution of hematopoiesis after autologous transplantation of hematopoietic cells cryopreserved in 7.5% dimethyl sulfoxide if compared to 10% dimethyl sulfoxide containing medium.
Cryobiology
; 67(3): 327-31, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24125911
13.
Prognostic Impact of Copy Number Alterations' Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy.
Cancers (Basel)
; 15(22)2023 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38001691
14.
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia.
Blood
; 116(1): 122-8, 2010 Jul 08.
Artigo
Inglês
| MEDLINE | ID: mdl-20395416
15.
Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.
Haematologica
; 96(9): 1344-50, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21659356
16.
The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; the results of multicenter, prospective Polish Adult Leukemia Group study.
Am J Hematol
; 86(5): 437-9, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21465518
17.
Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma.
Bone Marrow Transplant
; 56(6): 1297-1304, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33339899
18.
IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.
Sci Rep
; 11(1): 10017, 2021 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33976256
19.
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study.
Br J Haematol
; 150(1): 58-71, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20408846
20.
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
N Engl J Med
; 356(4): 348-59, 2007 Jan 25.
Artigo
Inglês
| MEDLINE | ID: mdl-17251531